-
Nutrition and Type 1 Diabetes: A Four-Part Series
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on medical nutrition therapy for the management of diabetes. Specifically, I was tasked with…
-
ADCES25: Thriving in Diabetes Care & Education
The last week was a whirlwind of learning, growing, connecting, and plenty of laughs. Because when a bunch of diabetes care and education specialists get together, you know you’ve found…
-
Is Full-Fat Dairy Back on the Table?
I’d be lying if I said the thought of drinking milk didn’t make my stomach grumble, and not in a good way. Admittedly, I’m one of the growing number of…
-
How Virtual Dietitians Are Expanding Access to Diabetes Care
For years, nutrition support has been an essential but underutilized part of diabetes care. Despite strong evidence that medical nutrition therapy improves outcomes, many people with diabetes have faced challenges…
-
Debunk the Junk: 4 Common Myths About Insulin Pumps
Starting on an insulin pump can feel like a big step, especially for someone who’s been managing their diabetes a certain way for years. But with the right support, it…
-
What’s the Deal with GLP-1 Microdosing?
Is Less Really More? When it comes to GLP-1 medications like Ozempic and Wegovy, that’s the question more providers and patients are starting to ask. Originally approved for type 2…
-
ADA Scientific Sessions: Expanding the Discussion to Include Weight Bias
This past weekend, I had the pleasure of attending the American Diabetes Association’s 85th Scientific Sessions in Chicago. It was a phenomenal gathering of researchers, clinicians, scientists, and experts in…
-
Obesity Care vs. Weight Loss: What’s the Difference?
The International Obesity Collaborative, a global alliance of professional organizations focused on improving obesity care, recently released a powerful consensus statement: obesity care and weight loss are not the same.…
-
Does CGM Tell the Whole Story? A Second Look at Lingo for Metabolic Monitoring
I recently revisited Lingo, Abbott’s direct-to-consumer continuous glucose monitoring (CGM) system, after a new wave of clients began seeking guidance on how to use it to support metabolic health, including…
-
Congratulations to the Graduating Class of 2025!
On May 30th, I had the opportunity to speak to the graduating dietetic interns at Children’s Hospital Colorado, sharing my journey from clinical care to entrepreneurship in diabetes care and…
-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss.…
-
GLP-1 Success Starts with Dietitian Leadership
It should come as no surprise that a large part of the success with incretin-based therapies— like Ozempic, Wegovy, Mounjaro, and Zepbound—stems from the effective integration of lifestyle modifications, particularly…
-
What Is Type 5 Diabetes? Exploring the Newest Diagnostic Category
If you’ve seen a new diabetes diagnosis category circulating in medical circles and found yourself confused, thinking, “I don’t remember learning about that type in medical, nursing, or dietetics school,”…
-
DCES Leadership in the Future of Wearable Health Technology
In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by…
-
GLP-1 Therapy Part 4: Navigating the Decision to Discontinue
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.…
-
GLP-1 Therapy Part 3: Strategies for Successful Weight Loss
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.…
-
GLP-1 Therapy Part 2: Preventing and Managing Side Effects
I recently had the pleasure of presenting at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.…
-
GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment.…
-
Double Diabetes: Supporting Patients Through the Diagnostic Overlap
If you’ve never heard the term “double diabetes” before, don’t be alarmed. It’s not an official diagnosis, and you likely won’t find it in a medical textbook. However, it’s a…
-
Blood Sugar Trends: Defining What’s Truly “Normal”
With the rise of direct-to-consumer continuous glucose monitoring, there has been growing interest in understanding blood sugar trends. Reasons for CGM use include to improve metabolic health, prevent diabetes, enhance…
